相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic review: Gene expression profiling assays in early-stage breast cancer
Luigi Marchionni et al.
ANNALS OF INTERNAL MEDICINE (2008)
Comparison of prognostic gene expression signatures for breast cancer
Benjamin Haibe-Kains et al.
BMC GENOMICS (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Inconsistent criteria used in American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Fatima Cardoso et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features
Lori J. Goldstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Development of the 21-gene assay and its application in clinical practice and clinical trials
Joseph A. Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical application of the 70-gene profile: The MINDACT trial
Fatima Cardoso et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia:: an analysis of 543 patients
Laura C. Collins et al.
MODERN PATHOLOGY (2007)
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system
Clifford A. Hudis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The prognostic role of a gene signature from tumorigenic breast-cancer cells.
Rui Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular targeted therapies in breast cancer: Where are we now?
Christian Widakowich et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
First-select the target:: better choice of adjuvant treatments for breast cancer patients
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2006)
TAILORx: Trial assigning individualized options for treatment (Rx)
Joseph A. Sparano
CLINICAL BREAST CANCER (2006)
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
Therese Sorlie et al.
BMC GENOMICS (2006)
Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000
LC Harlan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Molecular forecasting of breast cancer: Time to move forward with clinical testing
S Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients
Laurel A. Habel et al.
BREAST CANCER RESEARCH (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
M Colozza et al.
ANNALS OF ONCOLOGY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy
FJ Esteva et al.
CLINICAL CANCER RESEARCH (2005)
Gene-expression pro-files to predict distant metastasis of lymph-node-negative primary breast cancer
YX Wang et al.
LANCET (2005)
Cancer diagnostics - Decision criteria for marker utilization in the clinic
SE Taube et al.
AMERICAN JOURNAL OF PHARMACOGENOMICS (2005)
Breast cancer gene expression profiling: clinical trial and practice implications
S Loi et al.
PHARMACOGENOMICS (2005)
Treatment of lymph-node-negative, oestrogen-recept-postive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials
B Fisher et al.
LANCET (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Meeting highlights:: Updated international expert consensus on the primary therapy of early breast cancer
A Goldhirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
PM Ravdin et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
